NEWS

Latest updates

New Clinical Trial for Treatment in Prostate Cancer Patients with Specific Genetic Biomarkers

September 30, 2021

MiraDx, in collaboration with the UCLA Jonsson Comprehensive Cancer Center, is conducting a clinical trial to validate a novel prostate cancer biomarker panel designed to help assess patients who were at a greater risk of having long-term toxicity in response to their radiation treatment, to help guide treatment decisions. Treatment can involve radiation therapy, surgery, and/or hormone therapy Radiation has […]

Read More

ADDRESSES

CLIA certified and CAP Accredited Lab Address

Administrative Address

11601 Wilshire Blvd., Suite 2410, Los Angeles, CA, 90025

Information